Fortrea Holdings (FTRE) Deferred Taxes (2022 - 2026)
Fortrea Holdings' (FTRE) quarterly Deferred Taxes came in at $4.9 million in Q2 2026, up 148.04% YoY from $2.0 million in Q2 2025, and up 222.5% on a QoQ basis from -$4.0 million in Q1 2026.
Fortrea Holdings (FTRE) Deferred Taxes (2022 - 2026) Analysis & Trends
Fortrea Holdings (FTRE) has 5 years of Deferred Taxes data on file, last reported at $4.9 million in Q2 2026.
- Quarterly Deferred Taxes rose 148.04% year-over-year to $4.9 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$14.3 million (up 52.01% YoY) and the FY2025 annual result came in at -$32.0 million, down 30.08% from the prior year.
- Deferred Taxes advanced to $4.9 million in Q2 2026, from -$4.0 million in the prior quarter.
- In the past five years, Deferred Taxes ranged from a high of $4.9 million in Q2 2026 to a low of -$28.3 million in Q4 2023.
- A 5-year average of -$7.1 million and a median of -$7.6 million in 2025 frame the typical range for Deferred Taxes.
- The widest YoY moves for Deferred Taxes: up 216.67% in 2024, down 1655.56% in 2024.
- Tracing FTRE's Deferred Taxes over 5 years: stood at -$9.7 million in 2022, then plunged by 191.75% to -$28.3 million in 2023, then surged by 95.05% to -$1.4 million in 2024, then slumped by 442.86% to -$7.6 million in 2025, then soared by 164.47% to $4.9 million in 2026.
- The last three Deferred Taxes figures came in at $4.9 million (Q2 2026), -$4.0 million (Q1 2026), and -$7.6 million (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -69.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 194.40 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -137,876.64 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 2.66 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Fortrea Holdings | 1.66 Bn | 1.49 Bn | 139.20 Mn | 4.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.90 Mn |
| Mar 31, 2026 | -4.00 Mn |
| Dec 31, 2025 | -7.60 Mn |
| Sep 30, 2025 | -7.60 Mn |
| Jun 30, 2025 | -10.20 Mn |
| Mar 31, 2025 | -6.60 Mn |
| Dec 31, 2024 | -1.40 Mn |
| Sep 30, 2024 | -11.60 Mn |
| Jun 30, 2024 | -15.80 Mn |
| Mar 31, 2024 | 4.20 Mn |
| Dec 31, 2023 | -28.30 Mn |
| Sep 30, 2023 | -8.80 Mn |
| Jun 30, 2023 | -900,000.00 |
| Mar 31, 2023 | -3.60 Mn |
| Dec 31, 2022 | -9.70 Mn |